International infringement of U.S. intellectual property, including through counterfeiting, piracy, and outright IP theft, continues to take a significant toll on the U.S. economy.
IP Protection: Access To Medicine Is Important But So Is Its Continued Improvement
A recent op-ed by Joseph Stiglitz wrongly paints efforts to protect medical intellectual property (IP) as a grand conspiracy by drug companies. In fact, IP rights are a central tool for protecting the global innovation ecosystem and insuring that next generation medications and treatments make it to market.
You’re Ruining It for the Rest of Us: Ecuador and Intellectual Property
The IP environment in Ecuador, especially with regard to pharmaceuticals and biologics is shameful. And it is just one of a long line of countries doing so around the world, which risks perpetuating a global contagion effect.
Advertisers Take Big Step Forward to Reduce Facilitating Piracy
The Trustworthy Accountability Group (TAG) is creating a program to stop advertisers from placing advertisements on websites with unlicensed content or those offering counterfeit goods. This program shows that good faith stakeholders can and should come together to curb bad online activity, like the theft of copyrighted works, while creating jobs and incentivizing investment, innovation, and creativity.
Can Competition Hurt Innovation?
We need to ensure that pharmaceutical companies that invest smartly in new research are able to survive not by getting lucky but by having a diversified drug portfolio and sufficient continued revenue from past successes. By driving down profits, competition can decrease innovation by diminishing potential rewards. Policymakers should be wary of adverse side effects when sacrificing pharmaceutical profits for consumer welfare.
IPRs and Access to Medicines: New Evidence
Those in the global health community often allege that prices of new innovative drugs under patent make them unaffordable to most people in developing countries because of the absence of generic competition. A new report, however, finds good news about the relationship between IPRs and access to innovative medicines.
Landmark Trade Deal at Risk without Strong Intellectual Property Laws
The ambitious goal of creating a next-generation trade agreement through the completion of the Trans-Pacific Partnership, which aligns America with 11 of its trading partners across the Pacific region, is at risk of failing if negotiators cave in to pressures to strip it of strong intellectual property protections.